Jurox acquires Pitman-Moore's ethical division and production facility in Silverwater, Sydney - the first site to be Veterinary GMP accredited by the APVMA.
Jurox distributes Saffan an anaesthetic for cats and primates for Glaxo-Smith Klein.
Jurox subsidiary set up in Auckland, New Zealand.
Jurox launches Alfaxan – the first anaesthetic agent containing only the progesterone-analogue alfaxalone in a break-through novel formulation.
New 7 hectare facility opened moving all operations to the Hunter Valley, NSW Australia.
Jurox launch ready-to-use formulation of Alfaxan (alfaxalone 10 mg/mL).
The only 4 active combination sheep drench treating internal parasites.
EU accreditation for Jurox production facility through mutual recognition agreement between European regulators and the Australian TGA.
Giving dairy farmers an alternative to current mastitis treatments.
European registrations and distribution of Alfaxan in Belgium, France, Netherlands, Germany, Ireland and the United Kingdom.
Jurox protect Q-Drench and succeeds in formulation patent defense.
Canadian distribution of Alfaxan commences.
Jurox launches Promectin Plus Mini Allwormer Paste for Horses & Foals and Ponies, a concentrated broad spectrum horse all-wormer in a unique mini tube.
Alfaxan global registrations continue - product launched in Japan, Korea, USA.
Jurox open office in Malvern, UK.
The only cyclodextrin formulation on the market providing ease of syringability.
Alfaxan adds 10 new countries to its global registration list.
Bupredyne becomes available and registered for both cats and dogs in Australia and New Zealand.
Jurox move UK office to Crawley, West Sussex UK.
The launch of Buprelieve (buprenorphine 0.3 mg/mL) adds to UK portfolio.
StrikeForce-S contains dicyclanil in a unique solution, which provides long term blowfly strike protection in sheep.